Skip to content
Ostentus
  • Home
  • About us
    • Overview
    • Management
    • Directors
    • Advisors
  • R&D
    • Overview
    • Research Program
    • Timeline
    • OST-01
    • Presentations
  • News & Media
    • 2025 Publication
    • 2024 Publication
    • 2023
    • 2022
  • Investors
    • Investors Contact
  • Contact us
Ostentus
Close menu
  • Home
  • About us
    • Overview
    • Management
    • Directors
    • Advisors
  • R&D
    • Overview
    • Research Program
    • Timeline
    • OST-01
    • Presentations
  • News & Media
    • 2025 Publication
    • 2024 Publication
    • 2023
    • 2022
  • Investors
    • Investors Contact
  • Contact us
Ostentus
Toggle menu

News & Media

2024 Publication

OST-01, a natural product from Baccharis coridifolia, targets c-Myc-dependent ribogenesis in acute myeloid leukemia

Leukemia- Journal 1-17-2024

Call us

949-274-4761

Email us

info@ostentustherapeutics.com

Address

120 Newport Center Drive, Newport Beach, CA 92660

Copyright © Policy Ostentus Therapeutics Inc. 2025
Website Privacy Policy | Website Terms of Use | Privacy Policy for California Residents